Q1 2014 Holdings
Filed 2014-05-15 | 108 holdings | $746.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $498.3M | 20,481,442 | 66.8% |
| Biomarin Pharmaceuticals(BMRN) | COM | 09061G101 | $128.5M | 1,883,230 | 17.2% |
| Biocryst Pharmaceuticals Inc.(BCRX) | COM | 09058V103 | $62.1M | 5,867,031 | 8.3% |
| Cerus(CERS) | COM | 157085101 | $40.6M | 8,455,306 | 5.4% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $7.8M | 199,893 | 1.0% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $1.3M | 569,853 | 0.2% |
| Seattle Genetics, Inc. | COM | 812578102 | $944.9K | 20,739,426 | 0.1% |
| Synageva Biopharma Corp. | COM | 87159A103 | $883.5K | 10,648,182 | 0.1% |
| Pharmacyclics Inc. | COM | 716933106 | $875.7K | 8,737,888 | 0.1% |
| Incyte Corp.(INCY) | COM | 45337C102 | $794.0K | 14,835,559 | 0.1% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $779.0K | 11,600 | 0.1% |
| Salix 2.75% 5/15/15 | CONV BONDS | 795435AC0 | $492.0K | $219,440,000 | 0.1% |
| Genomic Health Inc.(GHDX) | COM | 37244C101 | $359.7K | 13,654,150 | 0.0% |
| Incyte Genomics Notes 1.25% 11/15/2020 144A | CONV BONDS | 45337CAL6 | $350.4K | $274,500,000 | 0.0% |
| Incyte Genomics Notes 0.375% 11/15/2018 144A | CONV BONDS | 45337CAK8 | $326.7K | $259,000,000 | 0.0% |
| Incyte Genomics Notes 4.75% 10/1/2015 144A | CONV BONDS | 45337CAJ1 | $245.9K | $40,446,000 | 0.0% |
| Intermune Inc. | COM | 45884X103 | $144.8K | 4,324,843 | 0.0% |
| Auxilium 1.5% 7/15/2018 | CONV BONDS | 05334DAA5 | $128.8K | $97,990,000 | 0.0% |
| Xoma Corp. | COM | 98419J107 | $120.1K | 23,057,572 | 0.0% |
| Intermune Inc Notes 2.5% 12/15/17 | CONV BONDS | 45884XAF0 | $107.9K | $41,000,000 | 0.0% |
| Intercept Pharmaceuticals, Inc.(ICPTUSD) | COM | 45845P108 | $84.6K | 256,375 | 0.0% |
| Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | $77.1K | $22,898,000 | 0.0% |
| Halozyme Therapeutics Inc.(HALO) | COM | 40637H109 | $72.4K | 5,698,139 | 0.0% |
| Vanda Pharmaceuticals, Inc.(VNDA) | COM | 921659108 | $72.2K | 4,445,696 | 0.0% |
| Gilead 1.625% 5/1/16 | CONV BONDS | 375558AP8 | $66.9K | $21,500,000 | 0.0% |
| Anacor Pharmaceuticals | COM | 032420101 | $61.9K | 3,095,318 | 0.0% |
| Medivation 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | $56.3K | $39,500,000 | 0.0% |
| Repros Therapeutics | COM | 76028H209 | $49.3K | 2,778,654 | 0.0% |
| Questcor Pharmaceuticals, Inc. | COM | 74835Y101 | $46.6K | 717,745 | 0.0% |
| Mirati Therapeutics Inc.(MRTXEUR) | COM | 60468T105 | $45.4K | 2,380,074 | 0.0% |
| Derma Sciences | COM | 249827502 | $44.9K | 3,537,137 | 0.0% |
| Gilead Sciences Inc.(GILD) | COM | 375558103 | $39.4K | 556,108 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $37.9K | 1,000,000 | 0.0% |
| Chelsea Therapeutics | COM | 163428105 | $37.3K | 6,760,394 | 0.0% |
| Clovis Oncology(CLVSEUR) | COM | 189464100 | $36.7K | 529,990 | 0.0% |
| Intermune Inc Notes 5% 3/1/15 | CONV BONDS | 45884XAD5 | $30.6K | $16,860,000 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $30.2K | 2,167,784 | 0.0% |
| Salix 1.5% 3/15/19 | CONV BONDS | 795435AE6 | $25.3K | $15,000,000 | 0.0% |
| Aegerion Pharmaceuticals | COM | 00767E102 | $23.7K | 513,922 | 0.0% |
| Dyax Corp. | COM | 26746E103 | $22.7K | 2,531,766 | 0.0% |
| Avanir Pharmaceuticals | COM Class A | 05348P401 | $21.3K | 5,790,139 | 0.0% |
| Xenoport | COM | 98411C100 | $20.9K | 4,034,112 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $18.2K | 4,449,797 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $15.4K | 1,211,851 | 0.0% |
| TG Therapeutics(TGTX) | COM | 88322Q108 | $14.9K | 2,160,965 | 0.0% |
| Biomarin Pharmaceuticals Notes 0.75% 10/15/2018 | CONV BONDS | 09061GAE1 | $13.7K | $12,500,000 | 0.0% |
| Kythera Biopharmaceuticals | COM | 501570105 | $12.4K | 311,255 | 0.0% |
| Arrowhead Research Corp. | COM | 042797209 | $12.0K | 732,062 | 0.0% |
| Insmed Inc.(INSM) | COM | 457669307 | $10.5K | 554,050 | 0.0% |
| Tekmire Pharmaceuticals Corp. | COM | 87911B209 | $10.4K | 484,156 | 0.0% |